Here is a complete breakdown of the mechanism of action of ephedrine:
Mechanism of Action of Ephedrine
Ephedrine is a mixed-acting sympathomimetic amine - it works through both direct and indirect pathways, with the indirect mechanism being predominant.
1. Indirect Mechanism (Predominant)
- Ephedrine is taken up by endocytosis into presynaptic postganglionic adrenergic nerve terminals
- Once inside, it displaces norepinephrine (NE) from synaptic vesicles
- The displaced NE is then released into the synapse, where it activates postsynaptic adrenergic receptors
- This leads to:
- Arterial and venous vasoconstriction (via alpha-1 receptors)
- Increased myocardial contractility (via beta-1 receptors)
This is similar in mechanism to amphetamine - it acts as a "false neurotransmitter" or displacing agent.
2. Direct Mechanism (Secondary)
- Ephedrine also directly stimulates alpha and beta-adrenoceptors, particularly beta receptors
- Direct beta stimulation somewhat limits the arterial pressure rise caused by alpha-mediated vasoconstriction (a self-balancing effect)
Receptor Profile Summary
| Receptor | Effect |
|---|
| Alpha-1 | Vasoconstriction, increased SVR |
| Beta-1 | Increased heart rate, increased contractility, increased cardiac output |
| Beta-2 | Bronchodilation (weaker, but present) |
3. Tachyphylaxis (Fading Effect)
A key feature: repeated doses cause tachyphylaxis. With successive doses, the pool of releasable norepinephrine in the nerve terminals is progressively depleted, so each subsequent dose is less effective. This does NOT happen with epinephrine, which acts directly on receptors without depending on NE release.
Net Cardiovascular Effects
Ephedrine's initial cardiovascular profile resembles epinephrine:
- Increased heart rate
- Increased cardiac output
- Increased systemic vascular resistance
- Increased blood pressure
However, it is less potent but has a longer duration of action than epinephrine.
CNS Effects
Because ephedrine (unlike epinephrine) crosses the blood-brain barrier, it also has CNS stimulant effects - it can cause arousal, anxiety, and insomnia. This property was historically used in nasal decongestants and asthma preparations.
Clinical Uses Based on MOA
- Hypotension under anesthesia (especially spinal/epidural anesthesia) - first-line when hypotension is accompanied by bradycardia
- Bronchospasm/asthma - via beta-2 bronchodilation
- Nasal congestion - via alpha-1 vasoconstriction in nasal mucosa
Source: Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e - "Ephedrine" section